title: Key questions of endocannabinoid signalling in the CNS: which, where and when?
authors: Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL, USA. cjfraz@ufl.edu
authors: Charles J
authors: CJ
authors: Frazier
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000502:physiology*; D063385:Cannabinoid Receptor Modulators / Q000502:physiology*; D063388:Endocannabinoids; D005989:Glycerides / Q000502:physiology*; D053444:Inhibitory Postsynaptic Potentials / Q000502:physiology*; D008071:Lipoprotein Lipase / Q000502:physiology*; D008297:Male; D009433:Neural Inhibition / Q000502:physiology*; D053284:Polyunsaturated Alkamides; D017397:Prefrontal Cortex / Q000502:physiology*
chemical_list: D001095:Arachidonic Acids; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D005989:Glycerides; D053284:Polyunsaturated Alkamides; C094503:glyceryl 2-arachidonate; D008071:Lipoprotein Lipase; C078814:anandamide